Mutations in BRCA1 and BRCA2 are present in only 35% to 40% of concentrated family clusters of breast/ovarian cancer; hence it is likely that other 'high-penetrance' breast cancer susceptibility genes remain to be identified. Here, BRCA1 is linked to ovarian carcinoma.